Literature DB >> 19004985

Immigration and the incidence of Graves' thyrotoxicosis, thyrotoxic multinodular goiter and solitary toxic adenoma.

Mikael Lantz1, Mirna Abraham-Nordling, Johan Svensson, Göran Wallin, Bengt Hallengren.   

Abstract

OBJECTIVE: Environmental and genetic factors influence thyrotoxicosis, but how population migration affects the disease panorama is not known. In an urban area in southern Sweden, during the years 1990 until 2003, the population increased from 232 000 to 267 000. In parallel, the proportion of inhabitants born outside Sweden increased. The aim was to investigate whether the incidence of Graves' thyrotoxicosis (GD), toxic multinodular goiter (TMNG), and solitary toxic adenoma (STA) has changed in Malmö since 1990 and to study the influence of geographic origin. DESIGN AND
METHOD: An open label prospective registration of thyrotoxicosis, gender, age, smoking habits, and ethnic background during 2003-2005 in an urban area in southern Sweden (Malmö) was undertaken.
RESULTS: The total incidence of thyrotoxicosis has changed from 43 to 41.6 cases/100,000/year from the years 1988-1990 to 2003-2005 (p-value 0.72). GD increased from 22 to 29.6 (p-value 0.0051), TMNG decreased from 16 to 9.9 (p-value 0.0011) and STA from 4.8 to 2.1 (p-value 0.0054)/100,000/year. The total incidence of GD was higher in inhabitants born outside Sweden up to the age of 69 years and age-specific incidence showed a peak in women aged 50-59 years old in both groups. The greatest difference between immigrants and Swedes up to the age of 69 years was observed in women aged 20-29 years old.
CONCLUSION: The incidence of GD has increased and of TMNG has decreased in Malmö since 1990. Geographic origin seems to affect the incidence of GD. Whether the observed peak in age-related incidence in women 50-59 years is explained by menopausal changes has to be further investigated.

Entities:  

Mesh:

Year:  2008        PMID: 19004985     DOI: 10.1530/EJE-08-0548

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  6 in total

Review 1.  The incidence and prevalence of thyroid autoimmunity.

Authors:  Donald S A McLeod; David S Cooper
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

2.  Corneal biomechanical changes and intraocular pressure in patients with thyroid orbitopathy.

Authors:  Zofia Pniakowska; Anna Klysik; Roman Gos; Piotr Jurowski
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

Review 3.  Selective IgA deficiency in autoimmune diseases.

Authors:  Ning Wang; Nan Shen; Timothy J Vyse; Vidya Anand; Iva Gunnarson; Gunnar Sturfelt; Solbritt Rantapää-Dahlqvist; Kerstin Elvin; Lennart Truedsson; Bengt A Andersson; Charlotte Dahle; Eva Ortqvist; Peter K Gregersen; Timothy W Behrens; Lennart Hammarström
Journal:  Mol Med       Date:  2011-08-04       Impact factor: 6.354

4.  Cancer risk in patients hospitalised for Graves' disease: a population-based cohort study in Sweden.

Authors:  X Shu; J Ji; X Li; J Sundquist; K Sundquist; K Hemminki
Journal:  Br J Cancer       Date:  2010-03-30       Impact factor: 7.640

5.  The Effect of Radioiodine Treatment on TRAb, Anti-TPO, and Anti-TG in Graves' Disease.

Authors:  Ola Lindgren; Pernilla Asp; Anna Sundlöv; Jan Tennvall; Bushra Shahida; Tereza Planck; Peter Åsman; Mikael Lantz
Journal:  Eur Thyroid J       Date:  2019-01-03

6.  Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial.

Authors:  Torquil Watt; Per Cramon; Jakob Bue Bjorner; Steen Joop Bonnema; Ulla Feldt-Rasmussen; Christian Gluud; Jeppe Gram; Jane Lindschou Hansen; Laszlo Hegedüs; Nils Knudsen; Pernille Bach-Mortensen; Runa Nolsøe; Birte Nygaard; Flemming Pociot; Maria Skoog; Per Winkel; Ase Krogh Rasmussen
Journal:  Trials       Date:  2013-04-30       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.